These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23197254)

  • 1. Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes.
    Anders K; Blankenstein T
    Clin Cancer Res; 2013 Jan; 19(2):320-6. PubMed ID: 23197254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
    Cohen PA; Peng L; Kjaergaard J; Plautz GE; Finke JH; Koski GK; Czerniecki BJ; Shu S
    Crit Rev Immunol; 2001; 21(1-3):215-48. PubMed ID: 11642606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor dormancy and oncogene addiction.
    Felsher DW
    APMIS; 2008; 116(7-8):629-37. PubMed ID: 18834407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
    Rak J; Yu JL
    Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer.
    Chouaib S; Meslin F; Thiery J; Mami-Chouaib F
    Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for cancer gene therapy.
    Hughes RM
    J Surg Oncol; 2004 Jan; 85(1):28-35. PubMed ID: 14696084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer.
    Anders K; Buschow C; Herrmann A; Milojkovic A; Loddenkemper C; Kammertoens T; Daniel P; Yu H; Charo J; Blankenstein T
    Cancer Cell; 2011 Dec; 20(6):755-67. PubMed ID: 22172721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making and circumventing tolerance to cancer.
    Kammertoens T; Blankenstein T
    Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular therapy to control tumor progression.
    Kapp M; Rasche L; Einsele H; Grigoleit GU
    Curr Opin Hematol; 2009 Nov; 16(6):437-43. PubMed ID: 19587587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathways: tumor cells Co-opt the brain-specific metabolism gene CPT1C to promote survival.
    Reilly PT; Mak TW
    Clin Cancer Res; 2012 Nov; 18(21):5850-5. PubMed ID: 22952346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-based gene therapy of cancer.
    Gill S; Kalos M
    Transl Res; 2013 Apr; 161(4):365-79. PubMed ID: 23246626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific peptides for the therapeutic targeting of oncogenes.
    Privé GG; Melnick A
    Curr Opin Genet Dev; 2006 Feb; 16(1):71-7. PubMed ID: 16377176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertical pathway targeting in cancer therapy.
    Shahbazian D; Sznol J; Kluger HM
    Adv Pharmacol; 2012; 65():1-26. PubMed ID: 22959021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of RNA interference therapy for cancer.
    Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
    Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.